Prostate Cancer
MRI characteristics and oncological follow-up of patients with ISUP grade group 4 or 5 prostate cancer.
November 2, 2023
Prognostic and therapeutic potential of senescent stromal fibroblasts in prostate cancer.
November 2, 2023
Outcomes of salvage robot-assisted radical prostatectomy in patients who had primary focal versus whole-gland ablation: a multicentric study.
November 2, 2023
Focal Therapy with High-Intensity Focused Ultrasound for Prostate Cancer: Three Year Outcomes from a Prospective Trial.
October 31, 2023
Making the Case for Autophagy Inhibition as a Therapeutic Strategy in Combination with Androgen-Targeted Therapies in Prostate Cancer.
October 31, 2023
Safety and tolerability of long-term treatment with darolutamide in patients with metastatic castration-resistant prostate cancer.
October 30, 2023
Biweekly vs Triweekly Cabazitaxel in Older Patients With Metastatic Castration-Resistant Prostate Cancer: The CABASTY Phase 3 Randomized Clinical Trial.
October 30, 2023
Deep learning-based ultrasound auto-segmentation of the prostate with brachytherapy implanted needles.
October 30, 2023
TALAPRO-3 clinical trial protocol: phase III study of talazoparib plus enzalutamide in metastatic castration-sensitive prostate cancer.
October 30, 2023
Modifiable risk factors for subsequent lethal prostate cancer among men with an initially negative prostate biopsy.
October 30, 2023
Clarity and PSI Kick Off SAR-bisPSMA Phase III
October 27, 2023